BioCatalystWatch
OSRHWorkspace / OSRH / OverviewCompany library
OSR Holdings, Inc. logo

OSR Holdings, Inc.

OSR Holdings, Inc. (OSRH)

Featured programme · VXM01

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Other pipelines

VXM01

VEGFR-2

PreINDP1P2P3FilingApproved
VXM04

Mesothelin (MSLN)

PreINDP1P2P3FilingApproved

BMP type II receptor × Activin A type II receptor

VXM04

Mesothelin (MSLN)

PreINDP1P2P3FilingApproved
VXM10

PD-L1

PreINDP1P2P3FilingApproved
RCT002

PreINDP1P2P3FilingApproved
VXM08

CEA

PreINDP1P2P3FilingApproved
VXM06

WT1

PreINDP1P2P3FilingApproved
RCT002

PreINDP1P2P3FilingApproved

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

OSRH PR & News

PR & News

OSRH SEC archive